LillyMedicareAnswers Patient Assistance Program

Lilly USA, LLC

The LillyMedicareAnswers program provides assistance to eligible patients prescribed FORTEO® (teriparatide [rDNA origin] injection), ZYPREXA® (olanzapine), or HUMATROPE® (somatropin [rDNA origin] for injection).
Contact Information
PO Box 66977
St. Louis, MO 63166-6977
1-(877) 795-4559 (phone)
1-(000) 000-0000 (fax)
1-877-RXLilly (vanity_phone)
Physician requests should be directed to:
PO Box 66977, St. Louis, MO. 63166-6977
1-(877) 795-4559 (phone)
How to Apply:
Select one of the links below to download the application or go to the program site for more information on how to apply. Once you fill out your application, send it to the address on the application. Do NOT send it to RxResource.
The key eligibility requirements for the LillyMedicareAnswers Program are: -Enrollment in a Medicare Part D plan -Not eligible for both Medicare and Medicaid (non-dual eligible people) -Income at or below at set percent of the Federal Poverty Level (FPL) -Proof of low-income subsidy denial -Signed certification that the patient will not claim or submit any cost incurred or associated with the medications provided under the LillyMedicareAnswers program towards their true-out-of-pocket-cost ("TROOP") calculation or submit any claim for reimbursement for the medications Once patients have enrolled in the LillyMedicareAnswers program, they are eligible to participate in the program for the rest of the calendar year, as long as they have a valid prescription for the medication. Patients must re-enroll in the program each year. Each refill, which is one month's supply of medication, will be shipped directly to the patient's home.
Other Information:
Patients will receive a letter notifying them if they have been enrolled in the program. The enrollment process should take approximately 2 weeks. Upon enrollment into the program, the patient will be shipped a monthly supply of each medication. If the prescription is for FORTEO or Humatrope, patients must also include a prescription for the injection supplies.
Product(s) covered by program:
  • Forteo®
  • Humatrope®
  • Zyprexa®